One system. One process. One partner.
Although pharmacovigilance (PV) and medical information (MI) are deeply interconnected, managing them separately often results in slower processes, duplicated work, and added regulatory pressure. For global pharma and biotech, these challenges only grow when multiplied across regions and diverse regulatory frameworks.
Biomapas unifies PV and MI in a single integrated solution, powered by
Nexentria’s platform, En3. One process, one team, and consistent oversight across all cases worldwide.
One Solution. Many Advantages.
- Compliance – Drive reliability and trust through harmonized processes, oversight, and systematic validation rules.
- Efficiency – Automation eliminates redundancies by streamlining case intake, triage, and reporting.
- Scalability – Manage higher volumes without higher costs.
- Visibility – Action items, dashboards, and analytics give full oversight.
- Focus – Free your teams to concentrate on science, strategy, and patient outcomes.
Designed for Global Pharma & Biotech
Global operations mean diverse regulations, a wide network of affiliates and stakeholders, multiple languages, and large volumes of safety data. Our integrated PV-MI solution, powered by En3, is designed to handle this complexity, providing international teams with a consistent process and central oversight while still meeting local requirements.
Why Biomapas
With PV and MI services in 70+ countries, Biomapas combines global reach with local expertise. Our integrated solution delivers consistency, quality, and efficiency, meeting regulatory requirements and advancing your strategic goals.
Take the Next Step
Unify PV and MI with Biomapas’ integrated solution. Streamline processes , strengthen oversight, and make operations more effective. Biomapas’ PV-MI solution is supported by technology from Nexentria. Together, we deliver a seamless, compliant, and scalable service for global pharma and biotech companies.
